JPMorgan downgrades Lululemon, sees stock moving sideways from here

JPMorgan downgraded Lululemon (LULU) to Neutral from Overweight, slashing its price target to $224, citing a normalizing pace of growth in China and significant U.S. product assortment challenges. The bank highlighted poor customer response to core seasonal colors, leading to elevated markdowns and promotional activities, which, combined with a deceleration from high growth rates in China, is expected to moderate revenue growth and constrain multiyear margins due to higher fixed costs. This outlook comes as LULU shares have already fallen 42% year-to-date, indicating a more challenging growth trajectory ahead.

Analysis

JPMorgan has downgraded Lululemon Athletica to Neutral from Overweight and substantially reduced its price target to $224 from $303, signaling minimal near-term upside. The downgrade is predicated on two core challenges: a normalization of growth in China and significant product assortment issues in the United States. In the U.S., a poor customer response to core seasonal colors, which represent approximately 40% of inventory, has forced the company into elevated markdowns and promotional events, such as the 'Summer Scores' campaign, to clear excess stock. This situation is compounded by the delay of new product catalysts until the second half of the year. Concurrently, growth in China is decelerating from a +48% compound annual growth rate (CAGR) experienced in FY23/24 to a more normalized trajectory closer to management's long-term target in the low-30s. While still a robust growth driver, this slowdown, combined with U.S. margin pressures and higher fixed SG&A costs, is expected to constrain the company's multiyear margin profile and moderate its overall revenue growth. This fundamental reassessment comes after the stock has already declined 42% year-to-date.

Key Decisions for Investors

• Given the fundamental challenges to both U.S. product momentum and China's growth rate, investors should re-evaluate long-term growth and margin assumptions, as the Neutral rating suggests a balanced risk-reward profile with limited near-term catalysts.
• Closely monitor inventory levels and gross margin performance in upcoming quarters, as the success of summer promotions and the reception of second-half product launches will be critical indicators of an operational turnaround.
• Adjust expectations for China to reflect a 'normalization' curve, anticipating a low-30s CAGR as guided by management, rather than the near-50% growth rates seen recently.
• Despite the stock's 42% year-to-date decline, the identified headwinds to revenue and margins warrant caution, and it may be prudent to await evidence of stabilization before increasing exposure.